Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-01-03 DAVIS STEPHEN Chief Operating Officer Grant or award · Stock Option (right to buy) +1,066,667 1,066,667
2013-11-20 TANG KEVIN C Director Grant or award +17,500,000 $0.40 $7.0M 81,713,600
2013-11-20 Quart Barry D Chief Executive Officer Purchase +1,000,000 $0.40 $400K 1,037,100
2013-07-18 Whelan John CFO Exercise or conversion +254,088 $0.26 $66K 254,088
2013-07-18 Whelan John CFO Exercise or conversion · Incentive Stock Option (right to buy) −254,088 393,366
2013-05-01 Rosen Robert President Grant or award · Stock Option (right to buy) +22,500,000 22,500,000
2013-05-01 Quart Barry D Chief Executive Officer Grant or award · Stock Option (right to buy) +22,500,000 22,500,000
2013-05-01 DAVIS STEPHEN Chief Operating Officer Grant or award · Stock Option (right to buy) +11,000,000 11,000,000
2013-05-01 Gelder Mark S. MD SVP & Chief Medical Officer Grant or award · Stock Option (right to buy) +2,000,000 2,000,000
2013-02-08 ADAM MICHAEL A Chief Operating Officer Grant or award · Stock Option (right to buy) +1,000,000 1,000,000
2013-02-08 Rosen Robert SVP & Chief Commercial Officer Grant or award · Stock Option (right to buy) +350,000 350,000
2013-02-08 Gelder Mark S. MD SVP & Chief Medical Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2013-02-08 Whelan John President, CEO and CFO Grant or award · Stock Option (right to buy) +1,750,000 1,750,000
2013-01-01 SPCH, LLC 10% owner Other disposition −36,190,476 0
2012-10-15 Rosen Robert SVP & Chief Commercial Officer Grant or award · Stock Option (right to buy) +10,000,000 10,000,000
2012-07-25 SPCH, LLLP 10% owner Purchase +38,095,238 $0.53 $20.0M 38,095,238
2012-07-25 TANG KEVIN C Director Grant or award +9,523,810 $0.53 $5.0M 69,960,316
2012-05-29 TANG KEVIN C Director Grant or award · Non-Qualified Stock Option (right to buy) +500,000 500,000
2012-05-29 GODDARD PAUL Director Grant or award · Non-Qualified Stock Option +500,000 500,000
2012-05-29 TURNBULL GREG Director Grant or award · Non-Qualified Stock Option +500,000 500,000

Page 40 of 45 · 881 trades